Effect of Restricting Contact Between Pharmaceutical Company Representatives and Internal Medicine Residents on Posttraining Attitudes and Behavior
McCormick, Brendan B.
Detsky, Allan S.
JAMA: The Journal of the American Medical Association 2001 October 24-31; 286(16): 1994-1999
Showing items related by title, author, creator and subject.
Rothenstein, Jeffrey M; Tomlinson, George; Tannock, Ian F; Detsky, Allan S (2011-10-19)Phase III clinical trials and Food and Drug Administration (FDA) regulatory decisions are critical for success of new drugs and can influence a company's market valuation. Knowledge of trial results before they are made ...
Lichstein, Peter R.; Turner, Robert C.; O'Brien, Kevin (1992-05)To survey internal medicine residency program directors regarding interactions between their residents and pharmaceutical company (PC) representatives (PCRs) a questionnaire was sent to the directors of all Accreditation ...